Evaluation of the novel vaginal contraceptive agent PPCM in preclinical studies using sperm hyaluronan binding and acrosome status assays.

North BB, Weitzel MB, Waller DP, Birch WX, Feathergill KA, Birch LA, De Jonge CJ, Prins GS

Open source

DOI
10.1111/andr.13110
Published
2022 Feb
Container
Andrology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/andr.13110,
  title = {Evaluation of the novel vaginal contraceptive agent PPCM in preclinical studies using sperm hyaluronan binding and acrosome status assays.},
  author = {North BB and Weitzel MB and Waller DP and Birch WX and Feathergill KA and Birch LA and De Jonge CJ and Prins GS},
  year = {2022},
  journal = {Andrology},
  doi = {10.1111/andr.13110},
  url = {https://doi.org/10.1111/andr.13110}
}

RIS

TY  - JOUR
TI  - Evaluation of the novel vaginal contraceptive agent PPCM in preclinical studies using sperm hyaluronan binding and acrosome status assays.
AU  - North BB
AU  - Weitzel MB
AU  - Waller DP
AU  - Birch WX
AU  - Feathergill KA
AU  - Birch LA
AU  - De Jonge CJ
AU  - Prins GS
PY  - 2022
JO  - Andrology
DO  - 10.1111/andr.13110
UR  - https://doi.org/10.1111/andr.13110
ER  - 

APA

BB, N., MB, W., DP, W., WX, B., KA, F., LA, B., CJ, D. J., & GS, P. (2022). Evaluation of the novel vaginal contraceptive agent PPCM in preclinical studies using sperm hyaluronan binding and acrosome status assays.. Andrology. https://doi.org/10.1111/andr.13110

Source records